| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Molecular and Cellular Biology, September 2007, p. 6012-6025, Vol. 27, No. 17
0270-7306/07/$08.00+0 doi:10.1128/MCB.00270-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
,
Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio,1 Division of Gastrointestinal Pathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts,2 Division of Signal Transduction, Department of Medicine, Beth Israel Deaconess Hospital, Boston, Massachusetts,3 Department of Systems Biology, Harvard Medical School, Boston, Massachusetts,4 Department of Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts5
Received 14 February 2007/ Returned for modification 5 April 2007/ Accepted 1 June 2007
K63 polyubiquitin chains spatially and temporally link innate immune signaling effectors such that cytokine release can be coordinated. Crohn's disease is a prototypical inflammatory disorder in which this process may be faulty as the major Crohn's disease-associated protein, NOD2 (nucleotide oligomerization domain 2), regulates the formation of K63-linked polyubiquitin chains on the I kappa kinase (IKK) scaffolding protein, NEMO (NF-
B essential modifier). In this work, we study these K63-linked ubiquitin networks to begin to understand the biochemical basis for the signaling cross talk between extracellular pathogen Toll-like receptors (TLRs) and intracellular pathogen NOD receptors. This work shows that TLR signaling requires the same ubiquitination event on NEMO to properly signal through NF-
B. This ubiquitination is partially accomplished through the E3 ubiquitin ligase TRAF6. TRAF6 is activated by NOD2, and this activation is lost with a major Crohn's disease-associated NOD2 allele, L1007insC. We further show that TRAF6 and NOD2/RIP2 share the same biochemical machinery (transforming growth factor ß-activated kinase 1 [TAK1]/TAB/Ubc13) to activate NF-
B, allowing TLR signaling and NOD2 signaling to synergistically augment cytokine release. These findings suggest a biochemical mechanism for the faulty cytokine balance seen in Crohn's disease.
Published ahead of print on 11 June 2007.
Supplemental material for this article may be found at http://mcb.asm.org/.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|